Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

 

Contacts:    Urologix:
   Stryker Warren, Jr., CEO
   (763) 475-1400

UROLOGIX REPORTS FISCAL 2008 FOURTH QUARTER & FISCAL YEAR 2008 RESULTS

MINNEAPOLIS — August 28, 2008 — Urologix®, Inc. (NASDAQ:ULGX), today reported financial results for the fourth quarter ended June 30, 2008 and for fiscal year 2008. Revenue for the fourth quarter was $3.7 million or 24 percent less than the $4.8 million reported in the same period of fiscal 2007 and 18 percent more than the $3.1 million reported in the third quarter of this fiscal year. Net loss for the fourth quarter was $2.2 million, or a loss of $0.16 per diluted share. This loss is compared to a net loss of $12.1 million or $0.84 per diluted share for the fourth quarter of fiscal 2007, and $2.1 million or $0.15 per diluted share in the third quarter of fiscal 2008.

Revenue for the entire fiscal year ended June 30, 2008 was $14.9 million or 30 percent less than the $21.3 million in revenue reported for fiscal year 2007. The net loss for the fiscal year ended June 30, 2008 was $14.9 million, or a loss of $1.04 per diluted share, compared to a net loss of $13.2 million, or a loss of $0.92 per diluted share, for the fiscal year ended June 30, 2007. The net loss for the fiscal year ended June 30, 2008 includes a net non-cash impairment charge of $8.6 million, or $0.60 per share taken in the quarter ended December 31, 2007. The net loss for the fourth quarter and fiscal year ended June 30, 2007 includes total non-cash charges of $11.2 million, or $0.78 per diluted share, consisting of a $6.4 million non-cash impairment and inventory write-down charge as well as a $4.8 million non-cash income tax charge to increase the Company’s tax valuation allowance. At June 30, 2008, the Company’s cash balance was $11.0 million, a decrease of $674,000 from the prior quarter.

Fourth quarter highlights included Urologix’ launch of the new CTC Advance Cooled ThermoTherapy treatment catheter at the American Urological Association (AUA) annual meeting in May 2008. Another highlight was the presentation at the AUA of interim five-year durability data from a multi-center study that demonstrated 90% freedom from secondary procedures with the Company’s CTC catheter. In addition, on June 24, 2008 the Company announced the appointment of Stryker Warren, Jr. as its Chief Executive Officer.

“While new to Urologix as an employee, I have had positive experience with the Company’s Cooled ThermoTherapy™ (CTT) technology dating back to 1997 when I was CEO of Urology Healthcare Group, a customer of Urologix at the time. In addition, since accepting the CEO role


The following information was filed by Urologix Inc (ULGX) on Friday, August 29, 2008 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Urologix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Urologix Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account